Sermonix Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sermonix Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10981
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company provides lead product such as lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting women that include various osteoporosis concerns. Sermonix also provides development of SERMs for breast health, treating vulvovaginal atrophy and for both the treatment and prevention of postmenopausal osteoporosis. The company provides oncology products through proof of concept, pre-clinical and clinical development programs, among others. Sermonix is headquartered in Columbus, Ohio, the US.

Sermonix Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Preferred Equity Bridge Financing 11
Sermonix Pharma Raises Funds through Seed Financing 12
Sermonix Pharma Raises USD1.5 Million in Financing Round 13
Sermonix Pharma Raises USD1 Million in Venture Financing 14
Licensing Agreements 15
Sermonix Pharma Enters into Licensing Agreement with Duke University 15
Sermonix Pharma Expands Licensing Agreement with Ligand Pharma for Lasofoxifene 16
Sermonix Pharmaceuticals LLC – Key Competitors 17
Sermonix Pharmaceuticals LLC – Key Employees 18
Sermonix Pharmaceuticals LLC – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sermonix Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sermonix Pharma Raises USD4.2 Million in Seed Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Preferred Equity Bridge Financing 11
Sermonix Pharma Raises Funds through Seed Financing 12
Sermonix Pharma Raises USD1.5 Million in Financing Round 13
Sermonix Pharma Raises USD1 Million in Venture Financing 14
Sermonix Pharma Enters into Licensing Agreement with Duke University 15
Sermonix Pharma Expands Licensing Agreement with Ligand Pharma for Lasofoxifene 16
Sermonix Pharmaceuticals LLC, Key Competitors 17
Sermonix Pharmaceuticals LLC, Key Employees 18

List of Figures
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sermonix Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sermonix Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). Its …
  • Agenus Inc (AGEN):企業の財務・戦略的SWOT分析
    Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Steris PLC:企業の戦略・SWOT・財務情報
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MTS Systems Corp (MTSC):企業の財務・戦略的SWOT分析
    Summary MTS Systems Corp (MTS) is an industrial equipment supplier that offers testing and sensing solutions. The company’s products include test components, actuators and hydraulic components, controllers, grips, fixtures and accessories, hydraulic power and distribution; environmental simulation s …
  • Stockland Corporation Ltd:企業のM&A・事業提携・投資動向
    Stockland Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stockland Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Philex Mining Corp:企業の戦略・SWOT・財務情報
    Philex Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Philex Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Beaver-Visitec International Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beaver-Visitec International Inc (BVI) is a manufacturer, developer and marketer of ophthalmic and other specialty microsurgical products. The product portfolio of the company includes knives, cannulae and fluid control products, electrosurgical devices, microsurgical instruments, drapes and …
  • Sarossa plc:企業の戦略的SWOT分析
    Sarossa plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Analog Devices Inc (ADI):企業の財務・戦略的SWOT分析
    Analog Devices Inc (ADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wellington Management Company LLP:企業の戦略・SWOT・財務情報
    Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report Summary Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Panasonic Corp (6752)
    Panasonic Corp (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Themis Bioscience GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Sun Hung Kai Properties Ltd:企業の戦略・SWOT・財務分析
    Sun Hung Kai Properties Ltd - Strategy, SWOT and Corporate Finance Report Summary Sun Hung Kai Properties Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MEI Pharma Inc (MEIP)-製薬・医療分野:企業M&A・提携分析
    Summary MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that offers clinical development of novel therapies for cancer. The company’s drug candidates comprise pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia, myelodysplastic …
  • Tech Data Corporation:企業の戦略・SWOT・財務情報
    Tech Data Corporation - Strategy, SWOT and Corporate Finance Report Summary Tech Data Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • British Polythene Industries Plc
    British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premi …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆